Redox regulation of cancer metastasis: Molecular signaling and therapeutic opportunities

Drug Development Research

Volumn 75, Issue 5, 2014, Pages 331-341

  Yang, Wenyong ^a,b,c   Zou, Linzhi ^a,b,c   Huang, Canhua ^c   Lei, Yunlong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

cancer therapy; metastasis; reactive oxygen species; redox sensors

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; PROTEIN P53; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; STAT3 PROTEIN; VASCULOTROPIN; ANTINEOPLASTIC AGENT;

CANCER THERAPY; HUMAN; IONIZING RADIATION; METASTASIS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; METABOLISM; MULTIMODALITY CANCER THERAPY; NEOPLASM METASTASIS; NEOPLASMS;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84906705556     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.21216     Document Type: Review

References (126)

1. Abdulghani J, Gu L, Dagvadorj A, Lutz J, Leiby B, Bonuccelli G, Lisanti MP, Zellweger T, Alanen K, Mirtti T, et al. 2008. Stat3 promotes metastatic progression of prostate cancer. Am J Pathol 172: 1717-1728.
2. Adams J,. 2004. The development of proteasome inhibitors as anticancer drugs. Cancer Cell 5: 417-421.
3. Aghajanian A, Wittchen ES, Campbell SL, Burridge K,. 2009. Direct activation of RhoA by reactive oxygen species requires a redox-sensitive motif. PloS one 4: e8045.
4. Antico Arciuch VG, Galli S, Franco MC, Lam PY, Cadenas E, Carreras MC, Poderoso JJ,. 2009. Akt1 intramitochondrial cycling is a crucial step in the redox modulation of cell cycle progression. PLoS ONE 4: e7523.
5. Artacho-Cordon F, Rios-Arrabal S, Lara PC, Artacho-Cordon A, Calvente I, Nunez MI,. 2012. Matrix metalloproteinases: potential therapy to prevent the development of second malignancies after breast radiotherapy. Surgical Oncol 21: e143-e151.
6. Ashour AE, Jamal S, Cheryan VT, Muthu M, Zoheir KM, Alafeefy AM, Abd-Allah AR, Levi E, Tarca AL, Polin LA, et al. 2013. CARP-1 functional mimetics: a novel class of small molecule inhibitors of medulloblastoma cell growth. PLoS ONE 8: e66733.
7. Barik S, Sureka K, Mukherjee P, Basu J, Kundu M,. 2010. RseA, the SigE specific anti-sigma factor of Mycobacterium tuberculosis, is inactivated by phosphorylation-dependent ClpC1P2 proteolysis. Mol Microbiol 75: 592-606.
8. Bellizzi A, Mangia A, Chiriatti A, Petroni S, Quaranta M, Schittulli F, Malfettone A, Cardone RA, Paradiso A, Reshkin SJ,. 2008. RhoA protein expression in primary breast cancers and matched lymphocytes is associated with progression of the disease. Inter J Mol Med 22: 25-31.
9. Bhandary B, Marahatta A, Kim HR, Chae HJ,. 2012. Mitochondria in relation to cancer metastasis. J Bioenerg Biomembr 44: 623-627.
10. Bollrath J, Greten FR,. 2009. IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis. EMBO Rep 10: 1314-1319.
11. Bouayed J, Bohn T,. 2010. Exogenous antioxidants-Double-edged swords in cellular redox state: health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid Med Cell Longev 3: 228-237.
12. Bouillet P, Strasser A,. 2002. BH3-only proteins-evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. J Cell Sci 115: 1567-1574.
13. Buricchi F, Giannoni E, Grimaldi G, Parri M, Raugei G, Ramponi G, Chiarugi P,. 2007. Redox regulation of ephrin/integrin cross-talk. Cell Adhesion Migration 1: 33-42.
14. Chaffer CL, Weinberg RA,. 2011. A perspective on cancer cell metastasis. Science 331: 1559-1564.
15. Chang L, Karin M,. 2001. Mammalian MAP kinase signalling cascades. Nature 410: 37-40.
16. Chen EI,. 2012. Mitochondrial dysfunction and cancer metastasis. J Bioenerg Biomembr 44: 619-622.
17. Chen W, Wu S, Zhang G, Wang W, Shi Y,. 2013. Effect of AKT inhibition on epithelial-mesenchymal transition and ZEB1-potentiated radiotherapy in nasopharyngeal carcinoma. Oncol Lett 6: 1234-1240.
18. Chiarugi P, Fiaschi T, Taddei ML, Talini D, Giannoni E, Raugei G, Ramponi G,. 2001. Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation. J Biol Chem 276: 33478-33487.
19. Chiu J, Dawes IW,. 2012. Redox control of cell proliferation. Trends Cell Biol 22: 592-601.
20. Cho KH, Choi MJ, Jeong KJ, Kim JJ, Hwang MH, Shin SC, Park CG, Lee HY,. 2014. A ROS/STAT3/HIF-1alpha signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion. Prostate 74: 528-536.
21. Clarke SJ, McStay GP, Halestrap AP,. 2002. Sanglifehrin a acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to Cyclophilin-D at a different site from Cyclosporin A. J Biol Chem 277: 34793-34799.
22. Colavitti R, Pani G, Bedogni B, Anzevino R, Borrello S, Waltenberger J, Galeotti T,. 2002. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J Biol Chem 277: 3101-3108.
23. Cross JV, Templeton DJ,. 2004. Oxidative stress inhibits MEKK1 by site-specific glutathionylation in the ATP-binding domain. Biochem J 381: 675-683.
24. Diao Y, Liu W, Wong CC, Wang X, Lee K, Cheung PY, Pan L, Xu T, Han J, Yates JR, 3rd, et al. 2010. Oxidation-induced intramolecular disulfide bond inactivates mitogen-activated protein kinase kinase 6 by inhibiting ATP binding. Proc Natl Acad Sci U S A 107: 20974-20979.
25. Diaz-Montero CM, Wang Y, Shao L, Feng W, Zidan AA, Pazoles CJ, Montero AJ, Zhou D,. 2012. The glutathione disulfide mimetic NOV-002 inhibits cyclophosphamide-induced hematopoietic and immune suppression by reducing oxidative stress. Free Radic Biol Med 52: 1560-1568.
26. Dickinson BC, Chang CJ,. 2011. Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat Chem Biol 7: 504-511.
27. Eble JA, de Rezende FF,. 2014. Redox-relevant aspects of the extracellular matrix and its cellular contacts via integrins. Antioxid Redox Signal 20: 1977-1993.
28. Faried A, Faried LS, Usman N, Kato H, Kuwano H,. 2007. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma. Ann Surgical Oncol 14: 3593-3601.
29. Finkel T,. 2012. Signal transduction by mitochondrial oxidants. J Biol Chem 287: 4434-4440.
30. Fogg VC, Lanning NJ, Mackeigan JP,. 2011. Mitochondria in cancer: at the crossroads of life and death. Chin J Cancer 30: 526-539.
31. Friedl P, Wolf K,. 2003. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3: 362-374.
32. Ghosh S, Erzurum SC,. 2011. Nitric oxide metabolism in asthma pathophysiology. Biochim Biophys Acta 1810: 1008-1016.
33. Giang AH, Raymond T, Brookes P, de Mesy Bentley K, Schwarz E, O'Keefe R, Eliseev R,. 2013. Mitochondrial dysfunction and permeability transition in osteosarcoma cells showing the Warburg effect. J Biol Chem 288: 33303-33311.
34. Giannoni E, Buricchi F, Grimaldi G, Parri M, Cialdai F, Taddei ML, Raugei G, Ramponi G, Chiarugi P,. 2008. Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival. Cell Death Diff 15: 867-878.
35. Giannoni E, Buricchi F, Raugei G, Ramponi G, Chiarugi P,. 2005. Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol Cell Biol 25: 6391-6403.
36. Giannoni E, Fiaschi T, Ramponi G, Chiarugi P,. 2009. Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals. Oncogene 28: 2074-2086.
37. Gilkes DM, Semenza GL,. 2013. Role of hypoxia-inducible factors in breast cancer metastasis. Future Oncol 9: 1623-1636.
38. Go YM, Jones DP,. 2008. Redox compartmentalization in eukaryotic cells. Biochim Biophys Acta 1780: 1273-1290.
39. Gorrini C, Harris IS, Mak TW,. 2013. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov 12: 931-947.
40. Gumireddy K, Li A, Cao L, Yan J, Liu L, Xu X, Pazoles C, Huang Q,. 2013. NOV-002, a glutathione disulfide mimetic, suppresses tumor cell invasion and metastasis. J Carcinog Mutagen 2013 Epub.
41. Gupta SC, Hevia D, Patchva S, Park B, Koh W, Aggarwal BB,. 2012. Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. Antioxid Redox Signal 16: 1295-1322.
42. Han YH, Moon HJ, You BR, Park WH,. 2009. The attenuation of MG132, a proteasome inhibitor, induced A549 lung cancer cell death by p38 inhibitor in ROS-independent manner. Oncol Res 18: 315-322.
43. Handy DE, Loscalzo J,. 2012. Redox regulation of mitochondrial function. Antioxid Redox Signal 16: 1323-1367.
44. Heo J, Raines KW, Mocanu V, Campbell SL,. 2006. Redox regulation of RhoA. Biochem 45: 14481-14489.
45. Hogg PJ,. 2013. Targeting allosteric disulphide bonds in cancer. Nat Rev Cancer 13: 425-431.
46. Horiuchi A, Imai T, Wang C, Ohira S, Feng Y, Nikaido T, Konishi I,. 2003. Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab Investig 83: 861-870.
47. Hsieh YH, Wu TT, Huang CY, Hsieh YS, Hwang JM, Liu JY,. 2007. p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells. Cancer Res 67: 4320-4327.
48. Huang X, Begley M, Morgenstern KA, Gu Y, Rose P, Zhao H, Zhu X,. 2003. Crystal structure of an inactive Akt2 kinase domain. Structure (1993) 11: 21-30.
49. Hynes RO,. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25.
50. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, Goldschmidt-Clermont PJ,. 1997. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275: 1649-1652.
51. Ivy SP, Wick JY, Kaufman BM,. 2009. An overview of small-molecule inhibitors of VEGFR signaling. Nat Rev Clin Oncol 6: 569-579.
52. Jaffe AB, Hall A,. 2005. Rho GTPases: biochemistry and biology. Ann Rev Cell Dev Biol 21: 247-269.
53. Janssen-Heininger YM, Mossman BT, Heintz NH, Forman HJ, Kalyanaraman B, Finkel T, Stamler JS, Rhee SG, van der Vliet A,. 2008. Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic Biol Med 45: 1-17.
54. Junttila MR, Ala-Aho R, Jokilehto T, Peltonen J, Kallajoki M, Grenman R, Jaakkola P, Westermarck J, Kahari VM,. 2007. p38alpha and p38delta mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells. Oncogene 26: 5267-5279.
55. Kang DH, Lee DJ, Lee KW, Park YS, Lee JY, Lee SH, Koh YJ, Koh GY, Choi C, Yu DY, et al. 2011. Peroxiredoxin II is an essential antioxidant enzyme that prevents the oxidative inactivation of VEGF receptor-2 in vascular endothelial cells. Mol Cell 44: 545-558.
56. Kilarkaje N, Al-Bader M,. 2013. Effects of antioxidants on drugs used against testicular cancer-induced alterations in metastasis-associated protein 1 signaling in the rat testis. Toxicol Ind Health. Epub.
57. Kim HS, Kim MJ, Kim EJ, Yang Y, Lee MS, Lim JS,. 2012. Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression. Biochem Pharmacol 83: 385-394.
58. Kincaid MM, Cooper AA,. 2007. ERADicate ER stress or die trying. Antioxid Redox Signal 9: 2373-2387.
59. Klaunig JE, Kamendulis LM,. 2004. The role of oxidative stress in carcinogenesis. Ann Rev Pharmacol Toxicol 44: 239-267.
60. Kwon J, Lee SR, Yang KS, Ahn Y, Kim YJ, Stadtman ER, Rhee SG,. 2004. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc Natl Acad Sci U S A 101: 16419-16424.
61. Lahoz A, Hall A,. 2008. DLC1: a significant GAP in the cancer genome. Genes Develop 22: 1724-1730.
62. Laurindo FR, Araujo TL, Abrahao TB,. 2014. Nox NADPH Oxidases and the endoplasmic reticulum. Antioxid Redox Signal. Epub.
63. Lee SH, Cheng H, Yuan Y, Wu S,. 2014. Regulation of ionizing radiation-induced adhesion of breast cancer cells to fibronectin by alpha5 beta1 integrin. Radiat Res Epub.
64. Lei Y, Huang K, Gao C, Lau QC, Pan H, Xie K, Li J, Liu R, Zhang T, Xie N, et al. 2011. Proteomics identification of ITGB3 as a key regulator in reactive oxygen species-induced migration and invasion of colorectal cancer cells. Mol Cell Proteomics 10: M110 005397.
65. Leonard SE, Reddie KG, Carroll KS,. 2009. Mining the thiol proteome for sulfenic acid modifications reveals new targets for oxidation in cells. ACS Chem Biol 4: 783-799.
66. Leto TL, Morand S, Hurt D, Ueyama T,. 2009. Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases. Antioxid Redox Signal 11: 2607-2619.
67. Levine RL, Stadtman ER,. 2001. Oxidative modification of proteins during aging. Exp Gerentol 36: 1495-1502.
68. Li F, Sonveaux P, Rabbani ZN, Liu S, Yan B, Huang Q, Vujaskovic Z, Dewhirst MW, Li CY,. 2007. Regulation of HIF-1alpha stability through S-nitrosylation. Mol Cell 26: 63-74.
69. Li L, Cheung SH, Evans EL, Shaw PE,. 2010. Modulation of gene expression and tumor cell growth by redox modification of STAT3. Cancer Res 70: 8222-8232.
70. Li XN, Song J, Zhang L, LeMaire SA, Hou X, Zhang C, Coselli JS, Chen L, Wang XL, Zhang Y, et al. 2009. Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin. Diabetes 58: 2246-2257.
71. Liu J, Shen W, Tang Y, Zhou J, Li M, Zhu W, Yang H, Wu J, Zhang S, Cao J,. 2014. Proteasome inhibitor MG132 enhances the antigrowth and antimetastasis effects of radiation in human nonsmall cell lung cancer cells. Tumour Biol. Epub.
72. Malhotra JD, Kaufman RJ,. 2007. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal 9: 2277-2293.
73. Mantel C, Messina-Graham SV, Broxmeyer HE,. 2011. Superoxide flashes, reactive oxygen species, and the mitochondrial permeability transition pore: potential implications for hematopoietic stem cell function. Curr Opin Hematol 18: 208-213.
74. Maria DA, de Souza JG, Morais KL, Berra CM, Zampolli Hde C, Demasi M, Simons SM, de Freitas Saito R, Chammas R, Chudzinski-Tavassi AM,. 2013. A novel proteasome inhibitor acting in mitochondrial dysfunction, ER stress and ROS production. Invest New Drugs 31: 493-505.
75. Matthews JR, Kaszubska W, Turcatti G, Wells TN, Hay RT,. 1993. Role of cysteine62 in DNA recognition by the P50 subunit of NF-kappa B. Nucleic Acids Res 21: 1727-1734.
76. Mor-Cohen R, Rosenberg N, Einav Y, Zelzion E, Landau M, Mansour W, Averbukh Y, Seligsohn U,. 2012. Unique disulfide bonds in epidermal growth factor (EGF) domains of beta3 affect structure and function of alphaIIb beta3 and alphav beta3 integrins in different manner. J Biol Chem 287: 8879-8891.
77. Muller M,. 2009. Cellular senescence: molecular mechanisms, in vivo significance, and redox considerations. Antioxid Redox Signal 11: 59-98.
78. Murphy MP,. 2009. How mitochondria produce reactive oxygen species. Biochem J 417: 1-13.
79. Myoui A, Nishimura R, Williams PJ, Hiraga T, Tamura D, Michigami T, Mundy GR, Yoneda T,. 2003. C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis. Cancer Res 63: 5028-5033.
80. Nam JS, Ino Y, Sakamoto M, Hirohashi S,. 2002. Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis. Clinical Cancer Res 8: 2430-2436.
81. Pani G, Giannoni E, Galeotti T, Chiarugi P,. 2009. Redox-based escape mechanism from death: the cancer lesson. Antioxid Redox Signal 11: 2791-2806.
82. Pani G, Galeotti T, Chiarugi P,. 2010. Metastasis: cancer cell's escape from oxidative stress. Cancer Metastasis Rev 29: 351-378.
83. Park MT, Kim MJ, Kang YH, Choi SY, Lee JH, Choi JA, Kang CM, Cho CK, Kang S, Bae S, et al. 2005. Phytosphingosine in combination with ionizing radiation enhances apoptotic cell death in radiation-resistant cancer cells through ROS-dependent and -independent AIF release. Blood 105: 1724-1733.
84. Pervaiz S, Taneja R, Ghaffari S,. 2009. Oxidative stress regulation of stem and progenitor cells. Antioxid Redox Signal 11: 2777-2789.
85. Pineda-Molina E, Klatt P, Vazquez J, Marina A, Garcia de Lacoba M, Perez-Sala D, Lamas S,. 2001. Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redox-induced inhibition of DNA binding. Biochem 40: 14134-14142.
86. Powell E, Piwnica-Worms D, Piwnica-Worms H,. 2014. Contribution of p53 to metastasis. Cancer Discov 4: 405-414.
87. Qiao M, Sheng S, Pardee AB,. 2008. Metastasis and AKT activation. Cell Cycle 7: 2991-2996.
88. Rehman J,. 2010. Empowering self-renewal and differentiation: the role of mitochondria in stem cells. J Mol Med 88: 981-986.
89. Reynaert NL, van der Vliet A, Guala AS, McGovern T, Hristova M, Pantano C, Heintz NH, Heim J, Ho YS, Matthews DE, et al. 2006. Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci U S A 103: 13086-13091.
90. Rhee SG, Kang SW, Jeong W, Chang TS, Yang KS, Woo HA,. 2005. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr Opin Cell Biol 17: 183-189.
91. Riemann A, Schneider B, Gundel D, Stock C, Thews O, Gekle M,. 2014. Acidic priming enhances metastatic potential of cancer cells. Pflugers Archiv. Epub.
92. San Martin A, Griendling KK,. 2010. Redox control of vascular smooth muscle migration. Antioxid Redox Signal 12: 625-640.
93. Sarsour EH, Kumar MG, Chaudhuri L, Kalen AL, Goswami PC,. 2009. Redox control of the cell cycle in health and disease. Antioxid Redox Signal 11: 2985-3011.
94. Seo JM, Park S, Kim JH,. 2012. Leukotriene B4 receptor-2 promotes invasiveness and metastasis of ovarian cancer cells through signal transducer and activator of transcription 3 (STAT3)-dependent up-regulation of matrix metalloproteinase 2. J Biol Chem 287: 13840-13849.
95. Smith TG, Robbins PA, Ratcliffe PJ,. 2008. The human side of hypoxia-inducible factor. Br J Haematol 141: 325-334.
96. Son Y, Kim S, Chung HT, Pae HO,. 2013. Reactive oxygen species in the activation of MAP kinases. Methods Enzymol 528: 27-48.
97. Sosa V, Moline T, Somoza R, Paciucci R, Kondoh H, Lleonart ME,. 2013. Oxidative stress and cancer: an overview. Ageing Res Rev 12: 376-390.
98. Steeg PS,. 2006. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12: 895-904.
99. Suda T, Takubo K, Semenza GL,. 2011. Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell 9: 298-310.
100. Summy JM, Gallick GE,. 2003. Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 22: 337-358.
101. Tanaka H, Matsumura I, Ezoe S, Satoh Y, Sakamaki T, Albanese C, Machii T, Pestell RG, Kanakura Y,. 2002. E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination. Mol Cell 9: 1017-1029.
102. Templeton DJ, Aye MS, Rady J, Xu F, Cross JV,. 2010. Purification of reversibly oxidized proteins (PROP) reveals a redox switch controlling p38 MAP kinase activity. PloS one 5: e15012.
103. Toker A, Marmiroli S,. 2014. Signaling specificity in the Akt pathway in biology and disease. Adv Biol Regul. Epub.
104. Torres M,. 2003. Mitogen-activated protein kinase pathways in redox signaling. Front Biosci 8: d369-d391.
105. Torres M, Forman HJ,. 2003. Redox signaling and the MAP kinase pathways. Bio Factors 17: 287-296.
106. Valastyan S, Weinberg RA,. 2011. Tumor metastasis: molecular insights and evolving paradigms. Cell 147: 275-292.
107. Velu CS, Niture SK, Doneanu CE, Pattabiraman N, Srivenugopal KS,. 2007. Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress. Biochemistry 46: 7765-7780.
108. Vousden KH, Ryan KM,. 2009. p53 and metabolism. Nat Rev Cancer 9: 691-700.
109. Vurusaner B, Poli G, Basaga H,. 2012. Tumor suppressor genes and ROS: complex networks of interactions. Free Radic Biol Med 52: 7-18.
110. Wagner EF, Nebreda AR,. 2009. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537-549.
111. Watson J,. 2013. Oxidants, antioxidants and the current incurability of metastatic cancers. Open Biol 3: 120144.
112. Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, et al. 2003. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 22: 319-329.
113. Weis S, Cui J, Barnes L, Cheresh D,. 2004. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J Cell Biol 167: 223-229.
114. Weissmueller S, Manchado E, Saborowski M, Morris JP, Wagenblast E, Davis CA, Moon SH, Pfister NT, Tschaharganeh DF, Kitzing T, et al. 2014. Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor beta signaling. Cell 157: 382-394.
115. Wilson WR, Hay MP,. 2011. Targeting hypoxia in cancer therapy. Nat Rev Cancer 11: 393-410.
116. Wirtz D, Konstantopoulos K, Searson PC,. 2011. The physics of cancer: the role of physical interactions and mechanical forces in metastasis. Nat Rev Cancer 11: 512-522.
117. Wybieralska E, Koza M, Sroka J, Czyz J, Madeja Z,. 2008. Ascorbic acid inhibits the migration of Walker 256 carcinosarcoma cells. Cell Mol Biol Lett 13: 103-111.
118. Xie TX, Wei D, Liu M, Gao AC, Ali-Osman F, Sawaya R, Huang S,. 2004. Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 23: 3550-3560.
119. Xie TX, Huang FJ, Aldape KD, Kang SH, Liu M, Gershenwald JE, Xie K, Sawaya R, Huang S,. 2006. Activation of stat3 in human melanoma promotes brain metastasis. Cancer Res 66: 3188-3196.
120. Xie Y, Kole S, Precht P, Pazin MJ, Bernier M,. 2009. S-glutathionylation impairs signal transducer and activator of transcription 3 activation and signaling. Endocrinology 150: 1122-1131.
121. Yang H, Lee HW, Kim Y, Lee Y, Choi YS, Kim KH, Jin J, Lee J, Joo KM, Nam DH,. 2013. Radiosensitization of brain metastasis by targeting c-MET. Lab Invest 93: 344-353.
122. Yang JQ, Zhao W, Duan H, Robbins ME, Buettner GR, Oberley LW, Domann FE,. 2001. v-Ha-RaS oncogene upregulates the 92-kDa type IV collagenase (MMP-9) gene by increasing cellular superoxide production and activating NF-kappaB. Free Radic Biol Med 31: 520-529.
123. Yasinska IM, Sumbayev VV,. 2003. S-nitrosation of Cys-800 of HIF-1alpha protein activates its interaction with p300 and stimulates its transcriptional activity. FEBS Lett 549: 105-109.
124. Zhang S, Wang Y, Li SJ,. 2014. Lansoprazole induces apoptosis of breast cancer cells through inhibition of intracellular proton extrusion. Biochem Biophys Res Commun. Epub.
125. Zhang XH, Wang Q, Gerald W, Hudis CA, Norton L, Smid M, Foekens JA, Massague J,. 2009. Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 16: 67-78.
126. Zhu P, Tan MJ, Huang RL, Tan CK, Chong HC, Pal M, Lam CR, Boukamp P, Pan JY, Tan SH, et al. 2011. Angiopoietin-like 4 protein elevates the prosurvival intracellular O2(-):H2O2 ratio and confers anoikis resistance to tumors. Cancer Cell 19: 401-415.